Table 1 Primary tumour characteristics of 123 patients
|  | MSLN-low (n = 45) | MSLN-high (n = 78) | Total (n = 123) | p-value | |
|---|---|---|---|---|---|
Age (years), median (range) | 47 (28–66) | 44 (26–72) | 45 (26–72) | 0.54 | |
Histology, n (%) | SCC | 34 (75.6) | 33 (42.3) | 67 (54.5) |  < 0.001 |
AC | 4 (8.9) | 23 (29.5) | 27 (22) | ||
ASC | 2 (4.4) | 11 (14.1) | 13 (10.6) | ||
GAS | 1 (2.2) | 11 (14.1) | 12 (9.8) | ||
NEC | 4 (8.9) | 0 (0) | 4 (3.3) | ||
FIGO stage (2008), n (%) | I | 34 (75.6) | 62 (79.5) | 96 (78.0) | 0.61 |
II | 11 (24.4) | 16 (20.5) | 27 (22.0) | ||
Tumour size, n (%) |  ≤ 4 cm | 27 (60) | 40 (51.3) | 67 (54.5) | 0.35 |
 > 4 cm | 18 (40) | 38 (48.7) | 56 (45.5) | ||
Lymph node metastasis, n (%) | Yes | 14 (31.1) | 31 (39.7) | 45 (36.6) | 0.34 |
No | 31 (68.9) | 47 (60.3) | 78 (63.4) | ||
Lymphovascular space invasion, n (%) | Yes | 20 (44.4) | 53 (67.9) | 73 (59.3) | 0.01 |
No | 25 (55.6) | 25 (32.1) | 50 (40.7) | ||
Postoperative RT, n (%) | Yes | 12 (26.7) | 32 (41) | 44 (35.8) | 0.11 |
No | 33 (73.3) | 46 (59) | 79 (64.2) | ||
Postoperative CRT, n (%) | Yes | 2 (4.4) | 11 (14.1) | 13 (10.6) | 0.09 |
No | 43 (95.6) | 67 (85.9) | 110 (89.4) | ||